Programmatic joint venture with CBC and APG targeting the acquisition and development of life sciences assets located in the major life sciences clusters in China.
Recapitalization of an existing portfolio in conjunction with the provision of growth capital, reflective of the sector’s secular trend in China owed to strong market fundamentals, demographic trends, and sustained government support.
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
.jpg?h=600&w=800&hash=A0A61821F5C7099C02B284AECE3BFA5F)
.jpg?h=1670&w=3711&hash=5CF2C5D7636FC18C56D7EAF2D32C0829){kind=logo}
.jpg?h=560&w=400&hash=163509F2A390DBE47825C9C00A8D8AFD)
